Fig. 1From: Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trialRenal Angiomyolipoma Volume in the Patients with the Tuberous Sclerosis Complex during the Study. Panel a shows the renal angiomyolipoma volume at each visit is expressed as a percentage of the baseline size. The dashed line represents 50% of the baseline value; data below the line indicate that the mean angiomyolipoma volume was reduced by 50% or more. Panel b shows the mean change (in milliliters) from the baseline values for renal angiomyolipoma volume. I bars indicate the standard errorsBack to article page